A pilot study using nabilone for symptomatic treatment in Huntington's disease
Adrienne Curtis1, Ian Mitchell, Smitaa Patel
1Department of Neuropsychiatry, Birmingham and Solihull Mental Health Foundation Trust, Edgbaston, Birmingham, United Kingdom. ade@rcare.co.uk
Summary
Nabilone was found to be safe and well-tolerated in a pilot study for Huntington
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Current treatments for HD symptoms are limited.
- Nabilone, a synthetic cannabinoid, has potential therapeutic applications.
Purpose of the Study:
- To evaluate the safety and tolerability of nabilone in patients with Huntington's disease.
- To assess the efficacy of nabilone in improving motor function, cognition, behavior, and neuropsychiatric symptoms in HD.
Main Methods:
- A double-blind, placebo-controlled, cross-over pilot study.
- 44 randomized patients with HD received either nabilone (1 or 2 mg) or placebo.
- Outcomes measured using the Unified Huntington's Disease Rating Scale (UHDRS) and Neuropsychiatric Inventory (NPI).
Main Results:
- Nabilone was safe and well-tolerated, with no psychotic episodes reported.
- Nabilone showed a trend towards improvement in chorea, behavior, and NPI scores.
- No significant differences were observed in total motor score or cognitive function.
Conclusions:
- Nabilone is a safe and well-tolerated option for managing HD symptoms.
- Further investigation in larger, longer randomized controlled trials is warranted.
- Nabilone may offer benefits for chorea, behavioral, and neuropsychiatric aspects of HD.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...